Titre du document

Changes in vocal loudness following intensive voice treatment (LSVT®) in individuals with Parkinson's disease: A comparison with untreated patients and normal age‐matched controls

Lien vers le document
Nom du corpus

Ortho

Auteur(s)
  • Lorraine O. Ramig PhD 1,2,3
  • Shimon Sapir PhD 2
  • Cynthia Fox MA, CCC‐SLP 4
  • Stefanie Countryman MA, CCC‐SLP 2
Affiliation(s)
  • Department of Speech Language and Hearing Sciences, University of Colorado–Boulder, Boulder, Colorado
  • Wilbur James Gould Voice Center, Denver Center for the Performing Arts, Denver, Colorado
  • Correspondence address: Wilbur James Gould Voice Research Center, Denver Center for the Performing Arts, 1245 Champa Street, Denver, Colorado 80204
  • National Center for Neurogenic Communication Disorders, Department of Speech and Hearing Sciences, Unviersity of Arizona, Tucson, Arizona
Langue(s) du document
Anglais
Revue

Movement Disorders

Éditeur
Wiley
Année de publication
2001
Type de publication
Journal
Type de document
Article
Résumé

This study assessed the impact of the Lee Silverman Voice Treatment (LSVT®) on vocal loudness [sound pressure level (SPL)] in a group of dysarthric individuals with idiopathic Parkinson's disease (IPD). Pre‐ to post‐treatment changes in SPL in the treated group were compared with changes in voice SPL during the same time in two control groups: individuals with IPD not treated with the LSVT® and in non‐disordered individuals, age‐matched to the patients. All subjects produced the same voice and speech tasks—sustaining vowel phonation, reading the “Rainbow Passage,” producing a short monologue, and describing a picture. These tasks were recorded at three different occasions: just prior to treatment, just after treatment, and 6 months following treatment. The individuals treated with LSVT® increased voice SPL from baseline to post‐treatment by an average of 8 dB and from baseline to 6 months follow‐up by an average of 6 dB. These changes were statistically significant and perceptibly audible. No significant changes in SPL were observed in the control groups during the time corresponding to the treatment and follow‐up. Differences in SPL between the treated and untreated patients at post‐treatment and follow‐up were statistically significant for all voice and speech tasks. These findings, along with others, provide additional support for the efficacy of the LSVT®. Mov. Disord. 16:79–83, 2001. © 2001 Movement Disorder Society.

Mots-clés d'auteur
  • LSVT®
  • Parkinson's disease
  • speech therapy
  • vocal loudness
  • dysarthria
Catégories WoS
  • 1 - science ; 2 - clinical neurology
Catégories Science-Metrix
  • 1 - health sciences ; 2 - clinical medicine ; 3 - neurology & neurosurgery
Catégories Scopus
  • 1 - Health Sciences ; 2 - Medicine ; 3 - Clinical Neurology
  • 1 - Life Sciences ; 2 - Neuroscience ; 3 - Neurology
Catégories INIST
  • 1 - sciences appliquees, technologies et medecines ; 2 - sciences biologiques et medicales ; 3 - sciences medicales
Score qualité du texte
7.549
Version PDF
1.3
Présence de XML structuré
Oui
Identifiant ISTEX
531A9FD63A9D9C568514238B7209E95B66D73BD4
Nom du fichier dans la ressource
ortho-ang_0220
ark:/67375/WNG-90ZVSZNC-2
Powered by Lodex 9.8.2